Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial.
暂无分享，去创建一个
P. Thompson | E. Steinhagen-Thiessen | K. Parhofer | B. von Stritzky | B. Hohenstein | V. Simha | P. Duell | Emil M Degoma | A. Vogt | P. Moriarty | S. P. Babirak | G. Manvelian | W. Ramlow | Yunling Du